Autopsy report · NCT02038699

A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Protocol not activated.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1, Phase 2
Sponsor: Jazz Pharmaceuticals
Sponsor type: Industry
Conditions: Advanced Glioblastoma; Advanced Colorectal Cancer; Advanced Triple-negative Breast Cancer; Advanced Non-small Cell Lung Cancer
Interventions: ONC201
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.